“…Most of these eells express the a/i T cell receptor whereas a small proportion (5-15%) express the yd T cell receptor. It is established that the afi T cells recognize antigen in context with MHC class I or class II molecules, but for the yd T cells little is known eoneerning expression of activation markers, activation requirements, antigenic repertoire and restriction elements used, yd T cells have been studied in a number of pathological conditions such as RA and JRA [2][3][4][5][6][7], leprosy [8], polymyositis [9], eoeliac disease [10][11], eancer [12][13][14], primary immunodeficiency syndrome [15,16], Behijet's disease [17], and infections with Epstein-Barr virus [18] and HIV-1 [19]. Promiscuous cytotoxicity exerted by yd T cells has been documented in vitro [20,21] Correspondence: Dr Jens Kjeldsen-Kragh, Red Cross and National Hospital Blood Centre, PO Box 6739, St Olavs Plass, N-0130 Oslo, Norway.…”